1Indah Permata Hati, 2Agung Putra, 3Titiek Sumarawati
1Postgraduate student of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
2,3Department of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
DOI : https://doi.org/10.47191/ijmra/v6-i12-22Google Scholar Download Pdf
ABSTRACT:
Alopecia is a dermatological disorder characterized by disturbances in the shorter anagen phase and longer telogen phase in the hair cycle. Therapy with irritant side effects and contact dermatitis, scalp allergies. causes increased hair loss. Alternative therapy using secretome hypoxia mesenchymal stem cells (SH-MSCs) which is safe and effective is an option. Objective to determine the effect of topical administration of SH-MSCs gel on IL-10 and TNF-α gene expression in Wistar rats with a fluconazole-induced alopecia-like model. In vivo experimental research using a Post Test Only Control Group Design research design. This study used 4 groups, namely 2 treatment groups and intervention with a topical SH-MSCs gel dose of 20 μL and a dose of 40 μL, 1 treatment group that did not receive intervention (base gel control) and 1 group of healthy mice. Skin tissue analysis was carried out on day 22 to assess IL-10 and TNF-α gene expression using the RT-PCR method. IL-10 gene expression using the One way Anova test obtained a value of 0.00 (p<0.05) so that there was a significant difference in IL-10 gene expression between groups in mice with the alopecia like model. The results of the TNF-α gene expression data with a value of 0.00 (p<0.05) showed significant differences between treatment groups. Administration of various doses of SH-MSCs topical gel increased IL-10 gene expression and decreased TNF-α gene expression in Wistar rats with a fluconazole-induced alopecia-like model, with the use of SH-MSCs topical gel at a dose of 40 μL having the greatest effect. most significant compared to other groups.
KEYWORDS:Alopecia like, SH-MHSCs topical gel, TNF-α, IL-10
REFERENCES1) Li Y, Wang G, Wang Q, Zhang Y, Cui L, Huang X. Exosomes Secreted from Adipose-Derived Stem Cells Are a Potential Treatment Agent for Immune-Mediated Alopecia. J Immunol Res. 2022;2022. doi:10.1155/2022/7471246
2) Dasanders Jbowen M. Effects of Interleukins, Colony-Stimulating Factor and Tumour Necrosis Factor on Human Hair Follicle Growth in Vitro: A Possible Role for Interleukin-1 and Tumour Necrosis Factor-a in Alopecia Areata. Vol 135.; 1996.
3) Ito T, Tokura Y. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata. Exp Dermatol. 2014;23(11):787-791. doi:10.1111/exd.12489
4) Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil Use in Dermatology, Side Effects and Recent Patents. Vol 6.; 2012.
5) Madrigal M, Rao KS, Riordan NH. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med. 2014;12(1). doi:10.1186/s12967-014-0260-8
6) Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of Alopecia Areata in Olmsted County, Minnesota, 1975 Through 1989. Mayo Clin Proc. 1995;70(7):628-633. doi:10.4065/70.7.628
7) Siiakma VK, Ol C;, Dawn T, Kumar B. PROFILE OF ALOPECIA AREATA IN NORTHERN INDIA.
8) Putra A, Widyatmoko A, Ibrahim S, et al. Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia. F1000Res. 2021;10:228. doi:10.12688/f1000research.51191.1
9) Xue M, Zhang X, Chen J, et al. Mesenchymal Stem Cell-Secreted TGF- β 1 Restores Treg/Th17 Skewing Induced by Lipopolysaccharide and Hypoxia Challenge via miR-155 Suppression. Stem Cells Int. 2022;2022. doi:10.1155/2022/5522828
10) Lee YJ, Park SH, Park HR, Lee Y, Kang H, Kim JE. Mesenchymal stem cells antagonize ifn-induced proinflammatory changes and growth inhibition effects via wnt/β-catenin and jak/stat pathway in human outer root sheath cells and hair follicles. Int J Mol Sci. 2021;22(9). doi:10.3390/ijms22094581
11) Deng W, Zhang Y, Wang W, et al. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle. Stem Cell Res Ther. 2021;12(1). doi:10.1186/s13287-021-02614-0
12) Putra A, Ridwan FB, Putridewi AI, et al. The role of tnf-α induced mscs on suppressive inflammation by increasing tgf-β and il-10. Open Access Maced J Med Sci. 2018;6(10):1779-1783. doi:10.3889/ oamjms.2018.404
13) Ho CH, Lan CW, Liao CY, Hung SC, Li HY, Sung YJ. Mesenchymal stem cells and their conditioned medium can enhance the repair of uterine defects in a rat model. Journal of the Chinese Medical Association. 2018;81(3):268-276. doi:10.1016/j.jcma.2017.03.013
14) Kuntardjo N, Dharmana E, Chodidjah C, Nasihun TR, Putra A. TNF-α-Activated MSC-CM Topical Gel Effective in Increasing PDGF Level, Fibroblast Density, and Wound Healing Process Compared to Subcutaneous Injection Combination. Majalah Kedokteran Bandung. 2019;51(1):1-6. doi:10.15395/mkb.v51n1.1479
15) Deng W, Zhang Y, Wang W, et al. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle. Stem Cell Res Ther. 2021;12(1). doi:10.1186/s13287-021-02614-0
16) Martinez-Lopez A, Montero-Vilchez T, Sierra-Sánchez Á, Molina-Leyva A, Arias-Santiago S. Advanced medical therapies in the management of non-scarring alopecia: Areata and androgenic alopecia. Int J Mol Sci. 2020;21(21):1-28. doi:10.3390/ijms21218390
17) Darlan DM, Munir D, Putra A, Jusuf NK. MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC. Journal of the Formosan Medical Association. 2021;120(1):602-608. doi:10.1016/j.jfma.2020.06.028
18) Zhao J, Hu L, Liu J, Gong N, Chen L. The effects of cytokines in adipose stem cell-conditioned medium on the migration and proliferation of skin fibroblasts in vitro. Biomed Res Int. 2013;2013. doi:10.1155/2013/578479
19) Chen L, Tredget EE, Wu PYG, Wu Y, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(4). doi:10.1371/journal.pone.0001886
20) Roddy GW, Oh JY, Lee RH, et al. Action at a distance: Systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells. 2011;29(10):1572-1579. doi:10.1002/stem.708
21) Jorgensen C. Mesenchymal stem cells immunosuppressive properties: Is it specific to bone marrow-derived cells? Stem Cell Res Ther. 2010;1(2). doi:10.1186/scrt15
22) Németh K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E 2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42-49. doi:10.1038/nm.1905
23) Sinclair RD. Healthy hair: What is it? In: Journal of Investigative Dermatology Symposium Proceedings. Vol 12. Nature Publishing Group; 2007:2-5. doi:10.1038/sj.jidsymp.5650046
24) Kristiningrum E. CONTINUING PROFESSIONAL DEVELOPMENT Akreditasi PP IAI-2 SKP Suplemen Untuk Rambut Sehat. Vol 45.; 2018.
25) Thompson Iii GR, Krois CR, Affolter VK, et al. Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort. Published online 2019. doi:10.1128/AAC
26) Matluobi D, Araghi A, Maragheh BFA, et al. Carvacrol promotes angiogenic paracrine potential and endothelial differentiation of human mesenchymal stem cells at low concentrations. Microvasc Res. 2018;115:20-27. doi:10.1016/j.mvr.2017.08.003
27) Kehl D, Generali M, Mallone A, et al. Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. NPJ Regen Med. 2019;4(1). doi:10.1038/s41536-019-0070-y
28) Putra A, Pertiwi D, Milla MN, et al. Hypoxia-preconditioned MSCs have superior effect in ameliorating renal function on acute renal failure animal model. Open Access Maced J Med Sci. 2019;7(3):305-310. doi:10.3889/oamjms.2019.04
29) Byun JW, Kim HJ, Na K, et al. Bone marrow-derived mesenchymal stem cells prevent alopecia areata development through the inhibition of NKG2D expression: A pilot study. Exp Dermatol. 2017;26(6):532-535. doi:10.1111/exd.13255
30) Ito T, Tokura Y. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata. Exp Dermatol. 2014;23(11):787-791. doi:10.1111/exd.12489
31) Tembhre MK, Sharma VK. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. British Journal of Dermatology. 2013;169(3):543-548. doi:10.1111/ bjd.12396
32) Gautam RK, Singh Y, Gupta A, Arora P, Khurana A, Chitkara A. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata. J Cosmet Dermatol. 2020;19(1):234-240. doi:10.1111/jocd.12970
33) Zhou C, Li X, Wang C, Zhang J. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. Clin Rev Allergy Immunol. 2021;61(3):403-423. doi:10.1007/s12016-021-08883-0
34) Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3. doi:10.1038/ nrdp.2017.11
Volume 06 Issue 12 December 2023
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 05 (May 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 May 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.